Biological Industries is now part of the Sartorius group. Click here for more


The Sartorius Group is a leading international partner of the biopharmaceutical industry and the research sector. We are helping biotech scientists and engineers across the entire globe to develop and manufacture medications from the first idea to production. So more people will have access to better medicine.

in 2019 sartorius acquired the majority stakes in Biological Industries, a cell culture media developer and manufacturer. These acquisition has significantly expanded our portfolio of cell and gene therapy, stem cell research and cell culture, allowing us to provide an industry-leading support service to our customers.

Biological Industries (BI) has 40 years’ experience in cell culture media development and manufacturing. Our products range from classical cell culture media to supplements and reagents for stem cell research and potential cell therapy applications to serum-free media and many other products for animal cell culture and molecular biology. We are committed to a culture of excellence through our advanced manufacturing and quality-control systems, superior regulatory expertise, in-depth market knowledge, and extensive technical customer-support, training and R&D capabilities. 

Our diverse portfolio of products and services includes all of the following:

  • Liquid and powdered cell culture medium
  • Sterile serum (Fetal Bovine Serum, Newborn, horse serum, etc.)
  • Novel serum-free and animal component-free media and supplements
  • Products for stem cell culture
  • Products for cytogenetics
  • Products for mycoplasma detection and treatment
  • Disinfectants
  • ECM-coated disposable plastic ware
  • Products for molecular biology
  • Contract manufacturing and custom formulations

The life sciences research and biotechnology market in Israel is unusually large and sophisticated and includes hundreds of R&D laboratories, as well as leading biotechnology manufacturing firms. Sartorius is the leading supplier in this market with our full range of animal cell culture and tissue culture products, as well as products for molecular biology.

Over the years we have established a reputation for fast delivery, and excellent technical support.

From the outset, our policy has been based on the need to maintain an active Research and Development program in all facets of company activities. The company has its own in-house R&D Department, and in addition, we maintain active contact with science-based companies and research institutions in Israel and abroad, including know-how agreements with several such institutions. These ongoing efforts have led to the introduction of a series of serum-free medium products, and a novel product line for stem cell research and CAR-T research, as well as many other products for cell culture and molecular biology.